Notably, a retrospective observational study reported that treatment modification based on symptoms or tumor markers (carcinoembryonic antigen, carbohydrate antigen 19-9, and CA125) resulted in longer OS compared with treatment changes based on definitive evidence of peritoneal disease determined by CT [74]. Here, CEACAM5 is linked to disease of peritoneum.